News & Analysis as of

Continuing Resolution Regulatory Agenda

Holland & Knight LLP

Holland & Knight Health Dose: March 19, 2025

Holland & Knight LLP on

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

Akin Gump Strauss Hauer & Feld LLP

Fall Congressional Outlook

Introduction - Congress returns from the August recess with a robust agenda and limited time to pursue it. The calendar is further constrained by the September 30 deadline to pass appropriations packages or a continuing...more

Polsinelli

Fall Congressional Forecast: Eye on Federal Funding and Health Care

Polsinelli on

Congress faces a crowded agenda this fall comprised of must-pass policy initiatives and potential political messaging opportunities in the lead up to the November midterm elections. With control of both chambers at stake, the...more

Mintz - ML Strategies

ML Strategies Lame Duck Update: Trade and China Tariffs

Mintz - ML Strategies on

With a dwindling number of in-session legislative days before the end of the current 116th Congress, the U.S. House of Representatives and Senate are working to conclude their work before adjourning at the end of the year....more

Akin Gump Strauss Hauer & Feld LLP

2020 Post-Election Outlook

Former Vice President Joe Biden has been elected to serve as the 46th President of the United States, crossing the 270 electoral vote threshold on Saturday, November 7, with a victory in Pennsylvania. His running mate, Sen....more

Foley & Lardner LLP

Health Care Policy Happenings - September 2018 #2

Foley & Lardner LLP on

Here are some key health care policy headlines from the past week that you may have missed. Congress - Legislation and Committee Activity - Bloomberg: Opioids Compromise Already in the Works in Congress – Congress is...more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide